{"slideshow_credits": null, "snippet": "The bump in the offer price, to more than $191 a share, or nearly $60 billion in cash and stock, is yet another twist in the year\u2019s longest and most contentious takeover battle.", "abstract": "The bump in the offer price, to more than $191 a share, or nearly $60 billion in cash and stock, is yet another twist in the year\u2019s longest and most contentious takeover battle.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}], "original": "By DAVID GELLES"}, "web_url": "http://dealbook.nytimes.com/2014/10/07/valeant-and-pershing-square-to-raise-offer-for-botox-maker-allergan/", "lead_paragraph": null, "headline": {"main": "Valeant and Pershing Square to Raise Offer for Botox Maker Allergan", "print_headline": "Takeover Bid for Allergan Is to Increase", "kicker": "DealBook"}, "_id": "5434732f38f0d86add490daa", "word_count": "544", "multimedia": [{"height": 126, "url": "images/2014/10/08/business/dbpix-botox/dbpix-botox-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/10/08/business/dbpix-botox/dbpix-botox-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 397, "url": "images/2014/10/08/business/dbpix-botox/dbpix-botox-articleLarge.jpg", "legacy": {"xlarge": "images/2014/10/08/business/dbpix-botox/dbpix-botox-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "397"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/10/08/business/dbpix-botox/dbpix-botox-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/10/08/business/dbpix-botox/dbpix-botox-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-10-07T19:10:38Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Ackman, William A", "name": "persons", "rank": "1"}, {"value": "Allergan Inc", "name": "organizations", "rank": "1"}, {"value": "Pershing Square Capital Management", "name": "organizations", "rank": "2"}, {"value": "Salix Pharmaceuticals Ltd", "name": "organizations", "rank": "3"}, {"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "rank": "4"}, {"value": "Botox (Drug)", "name": "subject", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "2"}, {"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "3"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}